Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322621805> ?p ?o ?g. }
- W4322621805 endingPage "70" @default.
- W4322621805 startingPage "47" @default.
- W4322621805 abstract "Acute ischemic stroke (AIS) is the leading cause of disability and one of the top causes of mortality worldwide. The current standard of care is reperfusion therapy including intravenous thrombolysis (IVT) and thrombectomy. However, these treatments have limitations as they have a limited therapeutic window. Hence, there is a vital need to develop neuroprotective agents to prevent brain injury, extend the reperfusion window, improve mortality, and reduce disability in AIS patients. Neuroprotective agents work by counteracting the detrimental biochemical and molecular events that result in irreversible ischemic damage. Numerous preclinical studies and clinical trials have been done on different agents. Thus far, all have been definitively unsuccessful in large trials. Currently, there are several challenges in translation from animal studies to human trials. It is important to understand the current evidence as well as past challenges in the development of neuroprotective strategies in AIS in order for a more strategic selection of agents to be studied, improve study designs and thus contribute to the development of effective neuroprotective agents. Newer agents have shown promise in neuroprotection, and human trials are ongoing. In this review, the mechanisms of action of different families of neuroprotective agents were discussed. The evidence for the efficacy of different drugs in each family of neuroprotective agents was also evaluated and the current research landscape in neuroprotection for AIS was summarized. The past challenges and limitations in clinical trials and proposed possible ways to address these issues were highlighted." @default.
- W4322621805 created "2023-03-01" @default.
- W4322621805 creator A5008382345 @default.
- W4322621805 creator A5011960122 @default.
- W4322621805 creator A5030296238 @default.
- W4322621805 creator A5040035231 @default.
- W4322621805 creator A5069605832 @default.
- W4322621805 creator A5083703081 @default.
- W4322621805 date "2023-02-28" @default.
- W4322621805 modified "2023-09-30" @default.
- W4322621805 title "Neuroprotective agents in acute ischemic stroke" @default.
- W4322621805 cites W1513883393 @default.
- W4322621805 cites W1579851907 @default.
- W4322621805 cites W1864738043 @default.
- W4322621805 cites W1913839478 @default.
- W4322621805 cites W1924621182 @default.
- W4322621805 cites W1964079871 @default.
- W4322621805 cites W1965002413 @default.
- W4322621805 cites W1968533773 @default.
- W4322621805 cites W1974898218 @default.
- W4322621805 cites W1975155970 @default.
- W4322621805 cites W1978346382 @default.
- W4322621805 cites W1978710583 @default.
- W4322621805 cites W1979561481 @default.
- W4322621805 cites W1980216865 @default.
- W4322621805 cites W1981881424 @default.
- W4322621805 cites W1989528243 @default.
- W4322621805 cites W1992177920 @default.
- W4322621805 cites W1997247642 @default.
- W4322621805 cites W2003263443 @default.
- W4322621805 cites W2009589582 @default.
- W4322621805 cites W2016656772 @default.
- W4322621805 cites W2024130574 @default.
- W4322621805 cites W2025606077 @default.
- W4322621805 cites W2026113882 @default.
- W4322621805 cites W2027819969 @default.
- W4322621805 cites W2041380305 @default.
- W4322621805 cites W2042424650 @default.
- W4322621805 cites W2044546810 @default.
- W4322621805 cites W2053442326 @default.
- W4322621805 cites W2060060832 @default.
- W4322621805 cites W2060638129 @default.
- W4322621805 cites W2071299041 @default.
- W4322621805 cites W2084404125 @default.
- W4322621805 cites W2091842118 @default.
- W4322621805 cites W2100233958 @default.
- W4322621805 cites W2102669443 @default.
- W4322621805 cites W2103320383 @default.
- W4322621805 cites W2113266091 @default.
- W4322621805 cites W2119942682 @default.
- W4322621805 cites W2123636141 @default.
- W4322621805 cites W2125872628 @default.
- W4322621805 cites W2133956375 @default.
- W4322621805 cites W2136280619 @default.
- W4322621805 cites W2143605991 @default.
- W4322621805 cites W2145840924 @default.
- W4322621805 cites W2148056291 @default.
- W4322621805 cites W2157170329 @default.
- W4322621805 cites W2214706654 @default.
- W4322621805 cites W2247323096 @default.
- W4322621805 cites W2324987368 @default.
- W4322621805 cites W2338716492 @default.
- W4322621805 cites W2507506174 @default.
- W4322621805 cites W2518303214 @default.
- W4322621805 cites W2529787649 @default.
- W4322621805 cites W2550765437 @default.
- W4322621805 cites W2592025523 @default.
- W4322621805 cites W2595336446 @default.
- W4322621805 cites W2605760644 @default.
- W4322621805 cites W2607350503 @default.
- W4322621805 cites W2624037974 @default.
- W4322621805 cites W2768010753 @default.
- W4322621805 cites W2772047362 @default.
- W4322621805 cites W2789470595 @default.
- W4322621805 cites W2791065855 @default.
- W4322621805 cites W2792146494 @default.
- W4322621805 cites W2801269890 @default.
- W4322621805 cites W2803713198 @default.
- W4322621805 cites W2807816203 @default.
- W4322621805 cites W2884780137 @default.
- W4322621805 cites W2901086519 @default.
- W4322621805 cites W2912515976 @default.
- W4322621805 cites W2944454298 @default.
- W4322621805 cites W2949246003 @default.
- W4322621805 cites W2964070886 @default.
- W4322621805 cites W2964259580 @default.
- W4322621805 cites W2983229842 @default.
- W4322621805 cites W2985819695 @default.
- W4322621805 cites W3008073330 @default.
- W4322621805 cites W3012530761 @default.
- W4322621805 cites W3014059074 @default.
- W4322621805 cites W3025871009 @default.
- W4322621805 cites W3033053040 @default.
- W4322621805 cites W3036595344 @default.
- W4322621805 cites W3037542909 @default.
- W4322621805 cites W3087367332 @default.
- W4322621805 cites W3097256238 @default.
- W4322621805 cites W3134310320 @default.